252
Articles
11.1K
Citations
3.5
avg. Impact Factor
45
h-index

Most Cited Articles of Department of Hematology and Medical Oncology in 2016

TitleJournalYearCitations
First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid TumorsClinical Cancer Research201643
Pooled analysis of prospective European studies assessing the impact of using the 21-gene Recurrence Score assay on clinical decision making in women with oestrogen receptor-positive, human epidermal growth factor receptor 2-negative early-stage breast cancerEuropean Journal of Cancer201643
Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamicsNature Communications201632
Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literatureCritical Reviews in Oncology/Hematology201631
Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant RecipientsOpen Forum Infectious Diseases201628
Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative diseaseEuropean Journal of Haematology201617
Infectious Complications after Umbilical Cord-Blood Transplantation from Unrelated DonorsMediterranean Journal of Hematology and Infectious Diseases201614
Advances in haploidentical stem cell transplantation for hematologic malignanciesLeukemia and Lymphoma20169
MassARRAY determination of somatic oncogenic mutations in solid tumors: Moving forward to personalized medicineCancer Treatment Reviews20169
Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)ESMO Open20168
Re-examining the relationship between active cytomegalovirus (CMV) infection and acute graft-versus-host disease in allogeneic stem cell transplant recipients in the era of real-time PCR CMV assaysTransplant International20165
Lack of evidence for a reciprocal interaction between bacterial and cytomegalovirus infection in the allogeneic stem cell transplantation settingTransplant International20163
Reply to the letter to the editor 'How much evidence isn't in evidence-based guidelines?' by Johnson et alAnnals of Oncology2016